Skip to main content
. Author manuscript; available in PMC: 2008 Jul 22.
Published in final edited form as: J Invest Dermatol. 2007 Mar 22;127(7):1647–1656. doi: 10.1038/sj.jid.5700776

Table 1. Baseline characteristics of the population.

All countries
together1
No skin cancer
(N=560)
Squamous-cell carcinoma (with or without
BCC) (N=224)

Basal-cell carcinoma (with no SCC) (N=131)
Number male
N (%) 384 (68.6) 171 (76.3) P=0.031 96 (73.3) P=0.292
Age (years)
 Mean (SD) 52.4 (12.0) 59.8 (9.2) P<0.001 56.5 (10.6) P<0.001
 Min–max 15.7–77.9 34.1–80.9 26.9–77.6
Time since Tx (years)
 Mean (SD) 11.9 (7.3) 15.8 (7.6) P<0.001 12.3 (7.0) P=0.559
 Min–max 0.2–35.7 1.8–36.8 1.3–37.0

BCC, basal-cell carcinoma; SCC, squamous-cell carcinoma; SD, standard deviation; Tx, transplantation.

1

The data for the five countries are provided separately in >Table S1.